Supreme Court of Connecticut
Glover v. Bausch & Lomb, Inc.
June 7, 2022343 Conn. 513
Summary
The court answered both certified questions in the affirmative. It held that the Connecticut Product Liability Act can support a failure-to-warn claim based on a medical-device manufacturer’s failure to report adverse events to the FDA or comply with postapproval requirements, provided the plaintiff proves the required causal connection. It also held that the CPLA’s exclusivity provision bars a CUTPA claim seeking personal-injury damages caused by the marketing of an allegedly defective product.